Related Experiment Videos
Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma
Beatriz Sánchez-Nieto1, Karen C Goset, Iván Caviedes
1Facultad de Física, Pontificia Universidad Católica de Chile, Santiago, Chile. bsanchez@fis.puc.cl
Summary
Predicting changes in pulmonary function tests after radiation therapy is complex. Chemotherapy, particularly doxorubicin-cyclophosphamide-paclitaxel, significantly impacts lung function independently of radiation dose.
Area of Science:
- Radiation Oncology
- Pulmonary Medicine
- Medical Physics
Background:
- Radiation therapy (RT) for breast cancer and lymphoma can affect lung function.
- Predicting changes in pulmonary function tests (ΔPFTs) is crucial for patient management.
Purpose of the Study:
- To develop multivariate predictive models for ΔPFTs based on pre-RT values.
- To identify dosimetric and non-dosimetric predictors of lung function changes after RT.
Main Methods:
- Prospective study of 66 patients undergoing RT for breast cancer/lymphoma.
- Measured spirometry, lung capacity, and diffusing capacity.
- Analyzed correlations between dosimetric parameters and ΔPFTs, including chemotherapy, age, and smoking status.
Main Results:
- Irradiated lung (IL) models showed correlations between RT dose and lung damage.
- RT alone caused minor, temporary restrictive defects.
- Doxorubicin-cyclophosphamide-paclitaxel chemotherapy induced significant late restrictive effects, independent of RT.
Conclusions:
- Dosimetric parameters alone are insufficient predictors of ΔPFTs.
- Multivariate models incorporating non-dosimetric factors, especially chemotherapy, are necessary.
- Late lung damage appears to have more serial characteristics than early damage.
